Abstract
I Koutsoubari, V Papaevangelou, GN Konstantinou. Pediatr Allergy Immunol. 2012;23(4):385–390 The aim of this pilot study was to assess the effect of a 3-week course of clarithromycin as an add-on to regular treatment, on symptom-free days and lung function, in asthmatic children experiencing an acute exacerbation. Participants included 40 children, ages 6 to 14 years, followed by the Allergy Department at the second pediatric clinic of the University of Athens with intermittent or mild persistent asthma, who presented with an acute asthma exacerbation during a predefined 2-year period. This was a prospective, open-label, randomized pilot study. Participants were randomized to 2 groups. The first group received 15 mg/kg of clarithromycin for 3 weeks in addition to their regular exacerbation …
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
